Publications Database

Anderson G. M. et al. (2007)

Effects of short- and long-term risperidone treatment on prolactin levels in children with autism.

February, 61(4), pp. 545-550.

Read Abstract (New Window)

Anderson G. M. (2008)

The potential role for emergence in autism.

Autism Research

1(1), pp. 18-30

Read Abstract (New Window)

Martin A. et al. (2003)

Low-dose fluvoxamine treatment of children and adolescents with pervasive developmental disorders: a prospective, open-label study.

Journal of Autism and Developmental Disorders

33(1), pp. 77-85

Read Abstract (New Window)

Martin A. et al. (2004)

Weight and leptin changes among risperidone-treated youths with autism: 6-month prospective data.

American Journal of Psychiatry

161(6), pp. 1125-1127

Read Abstract (New Window) Read Full (New Window)

McDougle C. J. et al. (1997)

Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective, open-label study.

Journal of the American Academy of Child and Adolescent Psychiatry

36 pp. 685-693

Read Abstract (New Window)

Tordjman S. et al. (2013)

Advances in the research of melatonin in autism spectrum disorders: literature review and new perspectives.

International Journal Molecular Sciences

14(10), pp. 20508-20542.

Read Abstract (New Window) Read Full (New Window)